Why the study?
Does adenylyl cyclase type VI improve cardiac sarcoplasmic reticulum calcium uptake in murine dilated cardiomyopathy?
Does adenylyl cyclase type VI improve cardiac sarcoplasmic reticulum calcium uptake in murine dilated cardiomyopathy?
Adenylyl cyclase type VI restores normal SERCA2a affinity for calcium and improves calcium uptake in a murine model of dilated cardiomyopathy, providing a mechanistic basis for its salutary effects in heart failure.
Hypothesis-generating in murine cardiomyopathy; leaves open clinical translation of adenylyl cyclase type VI in human heart failure.
Calcium malfunction plays a central role in heart failure. Here, we provide evidence that adenylyl cyclase type VI restores sarco(endo)plasmic reticulum 2a (SERCA2a) affinity for calcium and maximum velocity of cardiac calcium uptake by sarcoplasmic reticulum in murine dilated cardiomyopathy. Restoration of normal SERCA2a affinity for calcium is associated not only with decreased phospholamban protein expression but also with increased phospholamban phosphorylation by PKA activation. The ratio of phosphorylated ryanodine receptor 2 (RyR2) to RyR2 protein was increased, but the amount of phosphorylated RyR2 was unaffected. These data provide a possible mechanism by which adenylyl cyclase type VI (in contrast to other signaling elements associated with increased cAMP generation) has a salutary effect in the failing heart.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: